Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $759.39 million. The enterprise value is $666.38 million.

Market Cap	759.39M
Enterprise Value	666.38M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

RLMD has 104.89 million shares outstanding. The number of shares has increased by 30.89% in one year.

Current Share Class	104.89M
Shares Outstanding	104.89M
Shares Change (YoY)	+30.89%
Shares Change (QoQ)	+84.07%
Owned by Insiders (%)	4.68%
Owned by Institutions (%)	42.45%
Float	90.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.14
P/TBV Ratio	8.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.62

Current Ratio	14.62
Quick Ratio	14.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -94.05% and return on invested capital (ROIC) is -57.57%.

Return on Equity (ROE)	-94.05%
Return on Assets (ROA)	-50.24%
Return on Invested Capital (ROIC)	-57.57%
Return on Capital Employed (ROCE)	-64.18%
Weighted Average Cost of Capital (WACC)	6.70%
Revenue Per Employee	n/a
Profits Per Employee	-$3.38M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,022.31% in the last 52 weeks. The beta is 0.45, so RLMD's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+1,022.31%
50-Day Moving Average	6.12
200-Day Moving Average	3.48
Relative Strength Index (RSI)	57.30
Average Volume (20 Days)	1,443,069

Short Selling Information

The latest short interest is 6.19 million, so 5.90% of the outstanding shares have been sold short.

Short Interest	6.19M
Short Previous Month	6.04M
Short % of Shares Out	5.90%
Short % of Float	6.86%
Short Ratio (days to cover)	4.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.20M
Pretax Income	-57.39M
Net Income	-57.39M
EBITDA	n/a
EBIT	-56.20M
Earnings Per Share (EPS)	-$1.45

Full Income Statement

Balance Sheet

The company has $93.01 million in cash and n/a in debt, giving a net cash position of $93.01 million or $0.89 per share.

Cash & Cash Equivalents	93.01M
Total Debt	n/a
Net Cash	93.01M
Net Cash Per Share	$0.89
Equity (Book Value)	86.51M
Book Value Per Share	1.18
Working Capital	87.55M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-45.79M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	-45.79M
FCF Per Share	-$0.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.89%
Shareholder Yield	-30.89%
Earnings Yield	-7.56%
FCF Yield	-6.03%

Analyst Forecast

The average price target for RLMD is $12.40, which is 71.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.40
Price Target Difference	71.27%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2